8,728 Shares in The Cooper Companies, Inc. $COO Bought by Figure 8 Investment Strategies LLC

Figure 8 Investment Strategies LLC acquired a new stake in The Cooper Companies, Inc. (NASDAQ:COO) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 8,728 shares of the medical device company’s stock, valued at approximately $626,000.

Several other large investors have also bought and sold shares of COO. Root Financial Partners LLC grew its position in shares of Cooper Companies by 104.5% in the 4th quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock valued at $26,000 after buying an additional 162 shares during the last quarter. Avalon Trust Co acquired a new stake in shares of Cooper Companies in the second quarter valued at about $25,000. SJS Investment Consulting Inc. raised its position in shares of Cooper Companies by 107.5% during the first quarter. SJS Investment Consulting Inc. now owns 361 shares of the medical device company’s stock worth $26,000 after acquiring an additional 187 shares during the last quarter. Elevation Wealth Partners LLC raised its position in shares of Cooper Companies by 1,136.4% during the second quarter. Elevation Wealth Partners LLC now owns 408 shares of the medical device company’s stock worth $29,000 after acquiring an additional 375 shares during the last quarter. Finally, J.Safra Asset Management Corp acquired a new position in shares of Cooper Companies in the second quarter worth approximately $32,000. 24.39% of the stock is owned by institutional investors.

Cooper Companies Trading Up 0.9%

NASDAQ COO opened at $75.76 on Wednesday. The business has a 50 day simple moving average of $71.41 and a 200 day simple moving average of $71.18. The Cooper Companies, Inc. has a one year low of $58.89 and a one year high of $89.83. The stock has a market capitalization of $14.78 billion, a P/E ratio of 64.20, a P/E/G ratio of 1.99 and a beta of 0.83. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.27 and a quick ratio of 0.78.

Cooper Companies (NASDAQ:COO) last issued its earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share for the quarter, topping analysts’ consensus estimates of $1.10 by $0.11. The business had revenue of $1.08 billion during the quarter, compared to the consensus estimate of $1.05 billion. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The firm’s revenue for the quarter was up 7.9% on a year-over-year basis. During the same period in the previous year, the company posted $0.96 earnings per share. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Research analysts expect that The Cooper Companies, Inc. will post 4.63 earnings per share for the current year.

Analyst Ratings Changes

A number of analysts have weighed in on the stock. Mizuho set a $85.00 target price on shares of Cooper Companies and gave the company an “outperform” rating in a research report on Thursday, June 4th. Robert W. Baird lowered their price target on shares of Cooper Companies from $98.00 to $85.00 and set an “outperform” rating for the company in a report on Friday, June 5th. KeyCorp restated a “sector weight” rating on shares of Cooper Companies in a research report on Friday, June 5th. BNP Paribas Exane reduced their price objective on shares of Cooper Companies from $95.00 to $92.00 and set an “outperform” rating on the stock in a research note on Monday, June 8th. Finally, Stifel Nicolaus decreased their price objective on shares of Cooper Companies from $95.00 to $85.00 and set a “buy” rating for the company in a research report on Friday, June 5th. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, six have given a Hold rating and three have given a Sell rating to the company. According to data from MarketBeat.com, Cooper Companies has a consensus rating of “Hold” and a consensus price target of $81.64.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.